Article
Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior.
Blood advances - 23 Jan 2024
Wang Siao-Yi, Scurti Gina M, Dalheim Annika V, Quinn Suzanne, Stiff Patrick J, Nishimura Michael I
Abstract excerpt
ABSTRACT: CD19-specific chimeric antigen receptor (CAR) T cells have demonstrated impressive responses in patients with relapsed and refractory B cell malignancies. However, many patients relapse or fail to respond to CD19 CAR T cells, demonstrating the need to improve its efficacy and durability. Current protocols for generating CAR T cells involve T cell activation through CD3 stimulation to facilitate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
